Management

This page includes content on healthcare management, including health system, hospital, department and clinic business management and administration. Areas of focus are on cardiology and radiology department business administration. Subcategories covered in this section include healthcare economics, reimbursement, leadership, mergers and acquisitions, policy and regulations, practice management, quality, staffing, and supply chain.

Thumbnail

115-year-old Virginia imaging practice joins Strategic Radiology’s growing coalition

Radiology Associates of Richmond is the 28th such practice to make the move, marking the larger group’s 20th state and first foray into Virginia. 

Thumbnail

Hydroxychloroquine trial suspended by WHO

The World Health Organization has suspended the trial of the controversial drug hydroxychloroquine due to safety concerns.

Thumbnail

Radiology departments must look long-term to build financial resiliency after the pandemic

UW Seattle radiologists are cutting costs in the near-term to combat low imaging volumes, but say building future financial growth potential is key to a more stable outlook.

Thumbnail

Why the pandemic may be hitting female radiologists harder, and how hospitals and practices can counter

A recent study in JACR explored how video conferencing’s growing popularity in the profession may be having a negative impact on women. 

Thumbnail

Another COVID conference casualty: RSNA 2020 is going virtual

The Radiological Society of North America is canceling its annual meeting slated for later this year and moving the event to a web format. 

Thumbnail

Kaiser Permanente CIO to retire

Dick Daniels, chief information officer and vice president at Kaiser Permanente, announced his decision to retire mid-June.

Thumbnail

Radiologists see positives with ‘remote readouts’ and potential staying power in post-COVID future

Radiology trainees and attendings found relocating workspaces into reading "pods" overwhelmingly positive, and some aspects may be in place for the long-term.

Thumbnail

More Part D plans will likely offer $35 monthly co-pays for insulin in 2021

More than 1,750 standalone Medicare Part D prescription drug plans and MA plans have applied to offer insulin at a maximum $35 copay for a month’s supply of the drug for the 2021 plan year, CMS announced.